Survie à cinq ans des cancers bronchiques primitifs dans les centres hospitaliers généraux

Five year survival in lung cancer continues to be poor. As the risk factors for poor outcome at the time of diagnosis are not modifiable and pending the results of screening studies reduction in mortality must rest on primary prevention.